Clinical Trial Update: A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

View source ↗

Summary

A single-center clinical trial is evaluating the safety and efficacy of ublituximab in older adults with relapsing forms of multiple sclerosis, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ublituximab (ublituximab)

Snippet

Sponsor: Neurology Center of New England P.C. | Conditions: Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis | Status: RECRUITING